Eli Lilly And Company

OMVOH

Manufacturer:

Eli Lilly And Company

Omvoh HCPCS:

C9168

HCPCS Code Descriptor:

Injection, mirikizumab-mrkz, 1 mg

Category:

C Code

Omvoh NDCs:

00002-8011-27, 00002-7575-01

Primary Type:

Gastrointestinal

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00002-8011-27

About Omvoh:

OMVOH is aligned to the C Code: C9168. OMVOH is a Gastrointestinal product produced by Eli Lilly And Company and administered via the Subcutaneous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

C9168 Added Date:

4/1/24

C9168 Effective Date:

4/1/24

C9168 Deactive Date:

HCPCS Active

Omvoh billing and coding information can be found through Eli Lilly And Company at the link below:
Omvoh patient assistance information can be found through Eli Lilly And Company at the URL: https://www.omvoh.com/savings-support
OMVOH prescribing information can be found at the link below:
Information regarding OMVOH’s potential side effects can be found at MedlinePlus